Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML)

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

American Society of Hematology

Online

2021-07-22

DOI

10.1182/blood.2020009192

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started